Concepedia

Marine Gilabert

MG

Statistics

Publications

45

Citations

2.5K

H-Index

25

Active since

2005

Affiliations

Institut Paoli-Calmettes(Current)

Aix-Marseille Université

Inserm

Centre National de la Recherche Scientifique

Centre de Recherche en Cancérologie de Marseille

Marine Gilabert is an author at Institut Paoli-Calmettes specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2005–2024

45

Publications

45

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 312 citations · Full text

, , +16

Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes

Gwen Lomberk, Yuna Blum, Rémy Nicolle et al. · Nature Communications · 2018 · 277 citations · Full text

, , +17

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

Anthony Gonçalvès, Marine Gilabert, E. François et al. · Annals of Oncology · 2012 · 214 citations · Full text

, , +7

Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts

Rémy Nicolle, Yuna Blum, Laëtitia Marisa et al. · Cell Reports · 2017 · 196 citations · Full text

, , +17

Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome

Sònia Jiménez, Ángeles García‐Criado, Dolors Tàssies et al. · Lara D. Veeken · 2005 · 144 citations · Full text

, , +11

1–5 of 45